Terry W. Wright, Ph.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 850
Rochester, New York 14642

Office: 585 275-5944

Lab: 585 275-2234

Portrait

Dr. Wright's research interests are:

1) Pneumocystis carinii biology

2) Pathogenesis of lung injury during Pneumocystis carinii pneumonia.

The rapid clearance of bacterial and fungal pathogens is essential to preserve the delicate structure and critical function of the lung. The opportunistic pathogen, Pneumocystis carinii, colonizes the alveolar epithelium of patients suffering from a variety of immunodeficiencies, including AIDS. Dr. Wright's laboratory uses an immunologically reconstituted scid mouse model of P. carinii pneumonia (PCP) to study the host response to infection. Scid mice lack functional lymphocytes and therefore develop active P. carinii infections. However, the adoptive transfer of congenic spleen cells, including CD4+ T lymphocytes, to P. carinii-infected scid mice results in inflammatory cell recruitment to sites of infection and organism clearance. They are now examining the earliest molecular signals (including cytokine and chemokine expression) produced at epithelial sites of P. carinii colonization, to determine which cell types and which soluble mediators are involved in targeting inflammatory cell recruitment. These studies will not only further our understanding of PCP, but may also provide insight into general mechanisms of lung defense.

In addition, they are examining the role of pulmonary inflammation in the pathology of PCP. As stated above, an intense CD4+ T lymphocyte-dependent inflammatory response is mounted at sites of infection in reconstituted scid mice. In many cases this inflammatory response is productive, and serves to resolve the infection. However, under certain circumstances the inflammatory response may actually contribute to the pulmonary injury and respiratory impairment observed in P. carinii pneumonia. They have begun studies using physiological and molecular measurements of lung injury to assess the in vivo role of P. carinii-driven inflammation in PCP. They also plan to test specific anti-inflammatory agents to manipulate various aspects of the inflammatory response to determine the effect on lung injury. These studies will help define the role of inflammation in PCP, and further our understanding of pulmonary immunology.

Specialty

Infectious Diseases

Current Appointments

Education
PhD Microbiology and Immunology University of Rochester School of Medicine and Dentistry 1995
MS Microbiology and Immunology University of Rochester School of Medicine and Dentistry 1992
BS Biotechnology Rochester Institute of Technology 1990
Post-Doctoral Training & Residency
Pediatrics Postdoctoral Training, Division of Neonatology, University of Rochester School of Medicine and Dentistry, Rochester, NY 1995 - 1997
Fellowship Awards
NIH Postdoctoral Training Grant PI: Dr. Richard Hyde. HL 72061 "Multidisciplinary Training in Pulmonary Research" Goals: Pre- and post-graduate training of MD and PhD scientists in Pulmonary Research (7/1/77 - 8/31/02). 1995 - 1997
NIH Predoctoral Training Grant PI: Dr. Barbara H. Iglewski. 5-T32 AIO7362 "Molecular Pathogenesis of Bacteria and Viruses" Goals: Predoctoral training of PhD scientists in molecular pathogenesis. 1992 - 1995
Recent Journal Articles
Showing the 5 most recent journal articles. (39 available)
Pryhuber GS; Huyck HL; Bhagwat S; O'Reilly MA; Finkelstein JN; Gigliotti F; Wright TW. "Parenchymal cell TNF receptors contribute to inflammatory cell recruitment and respiratory failure in Pneumocystis carinii-induced pneumonia." Journal of immunology (Baltimore, Md. : 1950). 2008; 181(2):1409-19.
Wang J; Gigliotti F; Bhagwat SP; Maggirwar SB; Wright TW. "Pneumocystis stimulates MCP-1 production by alveolar epithelial cells through a JNK-dependent mechanism." American journal of physiology. Lung cellular and molecular physiology. 2007; 292(6):L1495-505. Epub 2007 Feb 16.
Wells J; Haidaris CG; Wright TW; Gigliotti F. "Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia." Infection and immunity. 2006; 74(1):390-3.
Wells J; Haidaris CG; Wright TW; Gigliotti F. "Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen." Infection and immunity. 2006; 74(4):2446-8.
Vitiello PF; Staversky RJ; Gehen SC; Johnston CJ; Finkelstein JN; Wright TW; O'Reilly MA. "p21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth." The American journal of pathology. 2006; 168(6):1838-47.